Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Biote Corp. - Class A common stock (NQ: BTMD )

5.980 -0.160 (-2.61%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Biote Corp. - Class A common stock

< Previous 1 2 3 Next >
InvestorNewsBreaks – Biote Corp. (NASDAQ: BTMD) Closes $31M Underwritten Public Offering
Via Investor Brand Network
Biote Announces Expiration and Results of Exchange Offer and Consent Solicitation Relating to Warrants
From Biote
Via Business Wire
Biote Announces Pricing of Secondary Offering of Common Stock
From biote Corp
Via Business Wire
Biote to Participate at Upcoming Investor Conferences
From biote Corp.
Via Business Wire
Biote Appoints Mary J. Puncochar as Chief Commercial Officer
From biote Corp.
Via Business Wire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Biote Reports First Quarter 2023 Financial Results
From Biote
Via Business Wire
Biote Announces Commencement of Exchange Offer and Consent Solicitation Relating to Warrants
From Biote
Via Business Wire
Biote Schedules First Quarter 2023 Financial Results Release and Conference Call
From biote Corp.
Via Business Wire
Biote Names John Denne as General Manager, Men’s Health Division
From Biote
Via Business Wire
Biote Reports Fourth Quarter and Full Year 2022 Financial Results
From Biote
Via Business Wire
Study: Testosterone Pellet Therapy Significantly Improves Bone Density in Male Patient Case Report
From Biote
Via Business Wire
Biote to Present at 35th Annual Roth Conference
From biote Corp.
Via Business Wire
Biote Schedules Fourth Quarter and Full Year 2022 Financial Results Release and Conference Call
From Biote Corp.
Via Business Wire
Over $4 Million Bet On Werewolf Therapeutics? Check Out These 4 Penny Stocks Insiders Are Buying
The Dow Jones closed higher on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks... 
Via Benzinga
Biote Announces Closing of Secondary Offering of 8,500,000 Shares of Common Stock Including Full Exercise of the Underwriters’ Over-Allotment Option
From biote Corp.
Via Business Wire
Biote Announces Pricing of Secondary Offering of Common Stock
From biote Corp
Via Business Wire
Biote to Present at Jefferies London Healthcare Conference
From biote Corp.
Via Business Wire
Biote Reports Third Quarter Financial Results
From Biote
Via Business Wire
Biote Appoints Debby Morris to Board of Directors
From biote Corp.
Via Business Wire
Biote Schedules Third Quarter 2022 Financial Results Release and Conference Call
From biote Corp.
Via Business Wire
Biote Releases Updated Corporate Presentation for October 2022
From biote Corp
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For September 27, 2022
Upgrades 
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
  
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
We're starting off the week with a breakdown of the biggest pre-market stock movers for Monday morning and the news moving them. 
Via InvestorPlace
Biote Announces Strategic Partnership with IMAC Holdings, Inc.
From biote Corp.
Via Business Wire
12 Health Care Stocks Moving In Friday's Pre-Market Session
  
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
We're starting off the final trading day of the week with an overview of the biggest pre-market stock movers for Friday! 
Via InvestorPlace
Why Pagerduty Is Trading Higher By 9%; Here Are 28 Stocks Moving Premarket
Gainers 
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers SenesTech (NASDAQ:SNES) stock rose 28.0% to $0.64 during Thursday's after-market session. The market value of their outstanding shares is at $7.8 million. 
Via Benzinga
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.